跳至主要内容
临床试验/JPRN-UMIN000051561
JPRN-UMIN000051561尚未招募4 期

Changes in subfoveal choroidal thickness after intravitreal Aflibercept for diabetic macular edema. - DME

MMU Mullana Ambala0 个研究点目标入组 100 人开始时间: 2024年1月1日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
45years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients with proliferative diabetic retinopathy, prior intravitreal injections of anti-VEGFs or laser photocoagulation, pars plana vitrectomy, age-related macular degeneration, venous occlusion, ocular trauma, pregnancy, and ocular surgery (except cataract surgery) were excluded. Patients with less than 6 months follow-up after the 3rd injection were excluded.

研究者

发起方
MMU Mullana Ambala

相似试验